A case report of thrombotic microangiopathy in a patient with advanced pancreatic carcinoma: an emerging, rare, and serious complication
dc.contributor.author | Kandari, S | en_US |
dc.contributor.author | Singh, A | en_US |
dc.contributor.author | Puri, R | en_US |
dc.contributor.author | Cheriyan, A | en_US |
dc.contributor.author | Kaur, S | en_US |
dc.date.accessioned | 2025-06-18T11:13:48Z | |
dc.date.available | 2025-06-18T11:13:48Z | |
dc.date.issued | 2025-06 | |
dc.description.abstract | Thrombotic microangiopathies are characterized by microangiopathic hemolytic anemia and end-organ damage following endothelial injury. The chemotherapeutic agents used in malignancy are one of the important causes of secondary TMA. Both malignancy and TMA are associated with significant morbidity and mortality. Timely recognition of both can result in early target-specific treatment initiation and better outcomes for both diseases. Here, we present a case of TMA in a patient with stage 4 pancreatic carcinoma being treated with Gemcitabine presented with acute kidney disease with new-onset hypertension, edematous illness, and anemia. The patient was Hemodialysis dependent and was treated with steroids, plasma exchange, and rituximab. The patient remained HD dependent 6 months post-treatment and was declared ESRD. Highlighting the importance of early recognition and timely treatment initiation. | en_US |
dc.identifier.affiliations | Department of Nephrology, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India | en_US |
dc.identifier.affiliations | Department of Nephrology, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India | en_US |
dc.identifier.affiliations | Department of Nephrology, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India | en_US |
dc.identifier.affiliations | Department of Nephrology, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India | en_US |
dc.identifier.affiliations | Department of Nephrology, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India | en_US |
dc.identifier.citation | Kandari S, Singh A, Puri R, Cheriyan A, Kaur S. A case report of thrombotic microangiopathy in a patient with advanced pancreatic carcinoma: an emerging, rare, and serious complication. International Journal of Advances in Medicine. 2025 Jun; 12(3): 308-310 | en_US |
dc.identifier.issn | 2349-3925 | |
dc.identifier.issn | 2349-3933 | |
dc.identifier.place | India | en_US |
dc.identifier.uri | https://imsear.searo.who.int/handle/123456789/248363 | |
dc.language | en | en_US |
dc.publisher | Medip Academy | en_US |
dc.relation.issuenumber | 3 | en_US |
dc.relation.volume | 12 | en_US |
dc.source.uri | https://doi.org/10.18203/2349-3933.ijam20251081 | en_US |
dc.subject | Thrombotic microangiopathy | en_US |
dc.subject | Gemcitabine induced-TMA | en_US |
dc.subject | Acute kidney disease | en_US |
dc.subject | Plasmapheresis | en_US |
dc.subject | Chemotherapy-associated complication | en_US |
dc.title | A case report of thrombotic microangiopathy in a patient with advanced pancreatic carcinoma: an emerging, rare, and serious complication | en_US |
dc.type | Journal Article | en_US |
Files
Original bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- ijam2025v12n3p308.pdf
- Size:
- 107.24 KB
- Format:
- Adobe Portable Document Format